EUVIMEDEUVIMED entdecken
Crossref

Ex vivo preservation of ovarian tissue using PEGylated fibrin hydrogel: a practical biomaterial-based strategy

Keyvan Sobhani, Amjad Farzinpour, Fardin Amidi, Saeid Moghassemi, Arezoo Dadashzadeh, Sarah Storder, Christiani A Amorim

Reproductive BioMedicine Online · 2025

DOI: 10.1016/j.rbmo.2025.105437 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reproductive BioMedicine Online, 2025. Verfasst von Keyvan Sobhani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pôle de Recherche en Physiopathologie de la Reproduction, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels…. Hauptthemen laut MEDLINE: Fertility Preservation, Ovarian Follicle, Tissue Scaffolds, Cryopreservation. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Ministry of Science Research and Technology, Fund for Scientific Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RESEARCH QUESTION: Can PEGylated fibrin hydrogel serve as a supportive three-dimensional scaffold to improve short-term survival of ovarian cortical tissue, which has implications for fertility preservation? DESIGN: Ovine ovarian cortical fragments were encapsulated in PEGylated fibrin hydrogel, synthesized by conjugating four-arm PEG-succinimidyl glutarate with fibrinogen (10:1 ratio) and cross-linked with thrombin and CaCl₂. Encapsulated and non-encapsulated tissues were cultured for 96 h. Morphological and functional assessments included histology, Masson's trichrome staining, immunohistochemistry for caspase-3 and vascular endothelial growth factor (VEGF), immunofluorescence for CD31, and lactate dehydrogenase cytotoxicity assays. RESULTS: Encapsulation significantly preserved primordial follicle density at 48 h (P = 0.01), and reduced degeneration of growing follicles at 72 h (P = 0.006). Stromal cell density was maintained in the encapsulated group at 48 h (P = 0.01), 72 h (P = 0.02) and 96 h (P = 0.001). The proportions of caspase-3-positive stromal cells and follicles were lower in encapsulated tissues at 72 h (P = 0.009 and P = 0.007, respectively), indicating that apoptosis may be reduced. Moreover, in the encapsulated group, the CD31-positive percentage area was elevated at 24 h (P = 0.05), 48 h (P < 0.0001) and 72 h (P = 0.001), whereas the proportion of VEGF-positive cells was higher at 48 h (P = 0.01) and 72 h (P = 0.05), suggesting enhanced angiogenic signalling. CONCLUSIONS: PEGylated fibrin hydrogel provides short-term cryoprotection by supporting stromal and follicular viability, and stimulating angiogenesis during ex-vivo ovarian tissue culture. These findings highlight its potential as a biomimetic scaffold in ovarian tissue engineering, although further optimization is required for extended culture periods and clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fertility PreservationOvarian FollicleTissue ScaffoldsCryopreservationTissue Culture TechniquesFemaleAnimalsModels, AnimalHydrogelsPolyethylene GlycolsBiocompatible MaterialsSheepTissue EngineeringBiomimetic Materials

Stichwörter der Autor:innen

AngiogenesisApoptosisFertility preservationFollicular survivalIn-vitro culturePEGylated fibrin hydrogel

Substanzen

HydrogelsPolyethylene GlycolsBiocompatible Materials

Autor:innen und Institutionen

  • Pôle de Recherche en Physiopathologie de la Reproduction, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium; Laboratory of Reproductive Physiology, University of Kurdis…
  • Laboratory of Reproductive Physiology, University of Kurdistan, Sanandaj, Kurdistan, Iran. Electronic address: Amjadfarzinpour@uok.ac.ir.
  • Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Pôle de Recherche en Physiopathologie de la Reproduction, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
  • Pôle de Recherche en Physiopathologie de la Reproduction, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium. Electronic address: christiani.amorim@uclouvain.be.

Förderung

  • Ministry of Science Research and Technology
  • Fund for Scientific Research

Zitieren

APA

Sobhani, K., Farzinpour, A., Amidi, F., Moghassemi, S., Dadashzadeh, A., Storder, S., & Amorim, C. A. (2025). Ex vivo preservation of ovarian tissue using PEGylated fibrin hydrogel: a practical biomaterial-based strategy. Reproductive BioMedicine Online. https://doi.org/10.1016/j.rbmo.2025.105437

Vancouver

Sobhani K, Farzinpour A, Amidi F, Moghassemi S, Dadashzadeh A, Storder S, et al. Ex vivo preservation of ovarian tissue using PEGylated fibrin hydrogel: a practical biomaterial-based strategy. Reproductive BioMedicine Online. 2025. doi:10.1016/j.rbmo.2025.105437

BibTeX
@article{Sobhani2025,
  author = {Sobhani, Keyvan and Farzinpour, Amjad and Amidi, Fardin and Moghassemi, Saeid and Dadashzadeh, Arezoo and Storder, Sarah and Amorim, Christiani A},
  title = {Ex vivo preservation of ovarian tissue using PEGylated fibrin hydrogel: a practical biomaterial-based strategy},
  journal = {Reproductive BioMedicine Online},
  year = {2025},
  doi = {10.1016/j.rbmo.2025.105437}
}
Kostenlos starten →